Edmond de Rothschild Investment Partners (EdRIP), Vesalius Biocapital Partners, Mitsubishi Pharma Corporate Venture and other investors have provided Swiss biopharma GenKyoTex with CHF 25m of early-stage funding.
Allßequitz backing for the heart pump developer also comes from Beteiligungsmanagement Thüringen
Deal is VC's sixth investment from its Deep-tech Fund
GP is currently investing via its Partech Entrepreneur Fund III and Paris Saclay Seed Fund
Fund targets European companies with expansion and growth plans in the Chinese market